Scinovex
review Open AccessTop 10% cited

Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

Alimentary Pharmacology & Therapeutics · 2006 · Vol. 23(8) · pp. 1097–1104
C. CanavanKeith R. AbramsJ F Mayberry

Abstract

Relative risk of colorectal and small bowel cancers are significantly raised in Crohn's disease. Cumulative risk of colorectal cancer of 2.9% at 10 years suggests a potential benefit from routine screening. However, the value of screening requires rigorous appraisal.

Inflammatory Bowel DiseaseMicroscopic ColitisGastric Cancer Management and OutcomesMedicineRelative riskColorectal cancerInternal medicineCrohn's diseaseDiseaseCancerMeta-analysisGastroenterologyRisk factor

MeSH terms

ColitisCrohn DiseaseHumansIleal NeoplasmsIleitisProbabilityRiskColorectal Neoplasms

Funding

  • University of Leicester
Citations
617
FWCI
10.47
field-weighted impact
References
39
Percentile
99%
vs. same field & year
Citations per year
Cited by
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
International Journal of Molecular Sciences · 2017 · 1,517 citations
ACG Clinical Guideline: Management of Crohn's Disease in Adults
The American Journal of Gastroenterology · 2018 · 1,376 citations
The Intestinal Microbiota and Colorectal Cancer
Frontiers in Immunology · 2020 · 592 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.